Jared Ebert
Ophthalmology · Washington, DCNPI 1790244572
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Alcon at 46.0% of the total.
Across 82 payments — averaging $75.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- AbbVie$610
- Alimera Sciences, Inc.$610
- Apellis Pharmaceuticals, Inc.$427
- Bausch & Lomb Americas Inc.$285
- Glaukos Corporation$235
- plus $1K from 13 others
What the payments were for
- Speaking & faculty fees$4607%
- Food & beverage$5,59191%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 39 | $2,828 |
| AbbVie(2 entities) | 10 | $610 |
| Alimera Sciences, Inc. | 2 | $610 |
| Apellis Pharmaceuticals, Inc. | 4 | $427 |
| Bausch & Lomb Americas Inc. | 3 | $285 |
| Glaukos Corporation | 2 | $235 |
| Regeneron Healthcare Solutions, Inc. | 6 | $212 |
| Eyepoint US, Inc. | 3 | $201 |
| ANI Pharmaceuticals, Inc. | 2 | $147 |
| Sight Sciences, Inc. | 1 | $130 |
| Amgen | 1 | $121 |
| Coherus Oncology, Inc. | 1 | $76 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $69 |
| Haag-streit USA, Inc. | 1 | $59 |
| Biotissue Holdings Inc. | 1 | $43 |
| Carl Zeiss Meditec USA, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Spark Therapeutics, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$1,512
- YUTIQ$739
- Iluvien$610
- STELLARIS$300
- Hydrus Microstent$253
- NGENUITY$241
- OZURDEX$226
- AcrySof IQ TORIC IOL$137
- OMNI(R) SURGICAL SYSTEM (US)$130
- Syfovre$125
- TEPEZZA$121
- PURIFIED CORTROPHIN GEL$119
- XIPERE$117
- IACCESS$113
- iStent inject W$113
- Centurion$106
How this compares
$6,151 in reported general payments places this provider in the 85th percentile of 74 ophthalmology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 54 | $2,471 |
| Ofloxacin | 56 | $562 |
| Latanoprost | 14 | $90 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Washington
- Wiley ChambersWashington$618K
- Keesha Williams ElliottWashington$167K
- Samuel StopakWashington$33K
- Jonca BullWashington$30K
- Leslie JonesWashington$22K
- Alexander HacopianWashington$13K
- Mehdi Tavakoli DastjerdiWashington$12K
- Andrew HammerWashington$11K
- Thandeka MyeniWashington$10K
- Dipak PanigrahiWashington$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.